Coherus Oncology (CHRS) Return on Equity [ROE] (2015 - 2026)
Coherus Oncology's Return on Equity [ROE] came in at -189.49% for Q2 2026, down 456.28 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2021, Coherus Oncology's Return on Equity [ROE] was -151.62%, down 220.11 percentage points from FY2020.
- Return on Equity [ROE] carries a five-year change of +1905.33 percentage points (FY2016 to FY2021).
- Going back by year, Return on Equity [ROE] was 68.49% in FY2020 (-201.19 pp), 269.68% in FY2019 and -955.26% in FY2017 (+1101.69 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q1 2022.
- Business Quant data shows CHRS's Return on Equity [ROE] at 266.79% (Q1 2026), 225.86% (Q4 2025) and 149.30% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.35 Bn | 1,259.96 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 655.58 Bn | 575.44 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 509.44 Bn | 477.50 Bn | 13.12 Bn | - |
| 4 | Merck | 362.14 Bn | 325.14 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 309.04 Bn | 282.62 Bn | - | - |
| 6 | Astrazeneca | 289.57 Bn | 263.55 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 248.97 Bn | 200.62 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.95 Bn | 182.98 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 170.25 Bn | 117.91 Bn | 12.56 Bn | 4.66% |
| 10 | Coherus Oncology | 115.85 Mn | -520.29 Mn | 10.07 Mn | -189.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -189.49% |
| Mar 31, 2026 | 266.79% |
| Dec 31, 2025 | 225.86% |
| Sep 30, 2025 | 149.30% |
| Mar 31, 2022 | -381.25% |
| Dec 31, 2021 | -251.31% |
| Sep 30, 2021 | -161.45% |
| Jun 30, 2021 | -116.39% |
| Mar 31, 2021 | -37.33% |
| Dec 31, 2020 | 49.28% |
| Sep 30, 2020 | 68.97% |
| Jun 30, 2020 | 97.60% |
| Mar 31, 2020 | 110.79% |
| Dec 31, 2019 | 111.43% |
| Sep 30, 2019 | -46.08% |
| Sep 30, 2018 | -527.81% |
| Jun 30, 2018 | -667.48% |
| Mar 31, 2018 | -1,513.94% |
| Dec 31, 2017 | -549.49% |
| Sep 30, 2017 | -600.35% |
API Access
Coherus Oncology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();